Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:DALS

DA32 Life Science Tech Acquisition (DALS) Stock Price, News & Analysis

DA32 Life Science Tech Acquisition logo

About DA32 Life Science Tech Acquisition Stock (NASDAQ:DALS)

Key Stats

Today's Range
$10.30
$10.32
50-Day Range
$10.25
$10.32
52-Week Range
$9.68
$11.22
Volume
2,200 shs
Average Volume
88,802 shs
Market Capitalization
$264.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York.

Receive DALS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DA32 Life Science Tech Acquisition and its competitors with MarketBeat's FREE daily newsletter.

DALS Stock News Headlines

Why I'm telling friends to avoid gold stocks
Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."
T. Rowe Price Science & Tech
Global Technology Acquisition Corp I (GTAC)
DA32 Life Science Tech Acquisition Corp.
See More Headlines

DALS Stock Analysis - Frequently Asked Questions

DA32 Life Science Tech Acquisition (DALS) raised $200 million in an initial public offering (IPO) on Wednesday, July 28th 2021. The company issued 20,000,000 shares at $10.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that DA32 Life Science Tech Acquisition investors own include Bridge Investment Group (BRDG), Blend Labs (BLND), Blue Foundry Bancorp (BLFY), Couchbase (BASE), ARYA Sciences Acquisition Corp V (ARYE), Argo Blockchain (ARBK) and a.k.a. Brands (AKA).

Company Calendar

Today
12/19/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Holding & other investment offices
Sub-Industry
N/A
Current Symbol
NASDAQ:DALS
Fax
N/A
Employees
2,021
Year Founded
N/A

Profitability

Net Income
$600,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
$0.02 per share
Book Value
($0.18) per share

Miscellaneous

Free Float
N/A
Market Cap
$264.71 million
Optionable
Not Optionable
Beta
N/A
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report

This page (NASDAQ:DALS) was last updated on 12/19/2024 by MarketBeat.com Staff
From Our Partners